Cyproterone PCD Pharma Franchise Company
Cafoli Lifecare offers Cyproterone as a tablet formulation, manufactured in WHO-GMP certified facilities. Distributors serving dermatology and gynaecology prescribers can secure district-wise monopoly franchise rights for this anti-androgen molecule with full promotional support.
What is Cyproterone?
Cyproterone acetate is a synthetic anti-androgen and progestogen that blocks the effects of male sex hormones. It is used - often combined with ethinylestradiol - to treat androgen-related conditions in women such as severe acne, hirsutism and signs of polycystic ovary syndrome. Reference: PubChem - Cyproterone acetate.
Available Forms
The Cafoli Cyproterone portfolio is offered as oral Tablets, including cyproterone-ethinylestradiol combinations. Contact us for current pack presentations and combinations.
Therapeutic Applications
Cyproterone is prescribed for moderate-to-severe acne and seborrhoea, hirsutism and androgenic symptoms of PCOS in women, and in certain androgen-dependent conditions in men. Prescribers include dermatologists, gynaecologists and endocrinologists.
Why Cyproterone is a High-Potential Molecule for Distributors
Acne, hirsutism and PCOS are extremely common concerns among young women, and anti-androgen therapy is prescribed for long, months-to-years courses by dermatologists and gynaecologists. That extended-course, specialist-driven use gives cyproterone dependable repeat demand in a large and growing women-health segment with limited PCD competition.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.
References
- PubChem: Cyproterone acetate
- PubMed: cyproterone in acne, hirsutism and PCOS
- MedlinePlus: Polycystic ovary syndrome
Our formulations of Cyproterone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: